Osteosarcoma
Pediatric Blood & Cancer2020Vol. 68(S2), pp. e28352–e28352
Citations Over TimeTop 1% of 2020 papers
Bree R. Eaton, Rudolf Schwarz, Ralph E. Vatner, Brian Yeh, L. Claude, Daniel J. Indelicato, Nadia N. Laack
Abstract
Osteosarcoma is a rare tumor that requires complex multidisciplinary management. This paper reviews the general management and standard radiotherapy guidelines for osteosarcoma in both North America and Europe in a joined effort between the Children's Oncology Group and International Society of Pediatric Oncology. Standard treatment involves multiagent induction chemotherapy followed by surgical resection for local tumor control and consolidation local control to metastatic sites. Radiotherapy is reserved for cases with a marginal or incomplete resection or for definitive treatment in the case of unresectable disease. We present supporting data for the role of chemotherapy, surgery, and radiation therapy.
Related Papers
- → Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma(2013)32 cited
- → Circular RNA circNRIP1 plays oncogenic roles in the progression of osteosarcoma(2021)27 cited
- A experimental study on chemosensitivity to Osteosarcoma in vitro(2013)
- → Atypical Cases of Osteosarcoma.(1991)
- → Diaphyseal osteosarcoma or synchronous osteosarcoma(2020)